MRI Findings of recurrent hepatocellular carcinoma after liver transplantation: Preliminary results
β Scribed by Chang Hee Lee; Lauren M. Brubaker; David A. Gerber; Young Mi Ku; Young Hoon Kim; Sang Soo Shin; Richard C. Semelka
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 371 KB
- Volume
- 33
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Purpose
To describe the patterns of recurrence and serial magnetic resonance imaging (MRI) features of hepatocellular carcinoma (HCC) after liver transplantation.
Materials and Methods
All cases of recurrent HCC after transplantation between September 2002 and August 2009 that underwent MRI including precontrast T1, T2βweighted images, and postgadolinium dynamic images were reviewed. On MRI we evaluated the characteristics and patterns of recurrent HCC after transplantation.
Results
A total 7 of 76 transplanted patients (four men, three women, age range, 45β63, mean 52.7 years) were included in this study. Four patients (57.1%) were identified to have a pattern of persistent local disease (PLD) near the transplanted liver, hepatorenal space, or suture site within 2.75 years (range, 2β4 years). Two patients showed recurrent HCC in the allograft alone within 5 years. One patient showed an intraperitoneal seeding (IPS) pattern which demonstrated diffuse peritoneal infiltration and thickening within 9 months. The diffuse metastatic disease (DMD) pattern was observed as a late manifestation of PLD and IPS. The most prominent volume of recurrent tumor burden was found in an extrahepatic (5 of 7 patients) compared to an intrahepatic (2 of 7 patients) location. The signal intensities and enhancement patterns did not exhibit change with disease progression.
Conclusion
We describe four patterns of recurrence of HCC following transplant. The most prominent tumor burden was located in an extrahepatic compared to an intrahepatic location. J. Magn. Reson. Imaging 2011;33:1399β1405. Β© 2011 WileyβLiss, Inc.
π SIMILAR VOLUMES
Very little is known about the natural history, effects of therapy, and survival after recurrence of hepatocellular carcinoma (HCC) after liver transplantation. All adult patients undergoing liver transplant from September 19, 1988, until September 19, 2002, were reviewed. Only patients with histolo
Tumor recurrence after liver transplantation for hepatocellular carcinoma is associated with a poor prognosis. Because immunosuppression is a well-known risk factor for tumor growth, it is surprising that its possible role in the outcome of liver transplantation has been poorly evaluated. We perform